Pages that link to "Q35817615"

The following pages link to Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis. (Q35817615):

Displaying 45 items.

• Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact (Q22299128) (← links)
• Extracellular HCV-core protein induces an immature regulatory phenotype in NK cells: implications for outcome of acute infection (Q30411437) (← links)
• Regulation of host innate immunity by hepatitis C virus: crosstalk between hepatocyte and NK/DC (Q30414152) (← links)
• NKG2D modulates aggravation of liver inflammation by activating NK cells in HBV infection (Q33669781) (← links)
• Persistent virus infection inhibits type I interferon production by plasmacytoid dendritic cells to facilitate opportunistic infections (Q33874809) (← links)
• Innate immune cell networking in hepatitis C virus infection (Q34341382) (← links)
• Genotype-Associated Differential NKG2D Expression on CD56+CD3+ Lymphocytes Predicts Response to Pegylated-Interferon/Ribavirin Therapy in Chronic Hepatitis C. (Q35597464) (← links)
• Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C. (Q35760543) (← links)
• The use of whey protein concentrate in management of chronic hepatitis C virus - a pilot study (Q35817765) (← links)
• Development of prophylactic and therapeutic vaccines against hepatitis C virus (Q36198667) (← links)
• Viral strategies for evading antiviral cellular immune responses of the host (Q36276589) (← links)
• Natural killer cells in hepatitis C virus infection: from innate immunity to adaptive immunity (Q36290084) (← links)
• Mechanisms of alcohol-induced hepatic fibrosis: a summary of the Ron Thurman Symposium (Q36406730) (← links)
• Altered innate immunity in chronic hepatitis C infection: cause or effect? (Q36948514) (← links)
• Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS. (Q37128253) (← links)
• Natural killer cell function is intact after direct exposure to infectious hepatitis C virions. (Q37224653) (← links)
• KLRG1 negatively regulates natural killer cell functions through the Akt pathway in individuals with chronic hepatitis C virus infection (Q37252732) (← links)
• Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases (Q37326768) (← links)
• Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis (Q37346066) (← links)
• Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride (Q37411006) (← links)
• Natural killer cell receptors and their ligands in liver diseases. (Q37417170) (← links)
• Exosomes derived from human menstrual blood-derived stem cells alleviate fulminant hepatic failure (Q37602609) (← links)
• Natural killer cells: versatile roles in autoimmune and infectious diseases (Q37754682) (← links)
• Progress in the development of vaccines for hepatitis C virus infection (Q38635596) (← links)
• MicroRNA-155 regulates interferon-γ production in natural killer cells via Tim-3 signalling in chronic hepatitis C virus infection (Q38899741) (← links)
• Non-pathogenic Sindbis virus causes hemorrhagic fever in the absence of alpha/beta and gamma interferons (Q40097417) (← links)
• Immune response of cytotoxic T lymphocytes and possibility of vaccine development for hepatitis C virus infection (Q40701361) (← links)
• Interferon- α -Induced Changes to Natural Killer Cells Are Associated with the Treatment Outcomes in Patients with HCV Infections (Q42119090) (← links)
• Different physiology of interferon-α/-γ in models of liver regeneration in the rat. (Q42857638) (← links)
• Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment (Q43037932) (← links)
• Significance of alterations in PBMC immunophenotype of children with chronic viral hepatitis C-- the role of dendritic cells (Q44156739) (← links)
• Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions. (Q44837814) (← links)
• NKG2D-retinoic acid early inducible-1 recognition between natural killer cells and Kupffer cells in a novel murine natural killer cell-dependent fulminant hepatitis (Q46141816) (← links)
• TLR4 agonists as immunomodulatory agents (Q50076068) (← links)
• Sustained response to interferon-alpha plus ribavirin therapy for chronic hepatitis C is closely associated with increased dynamism of intrahepatic natural killer and natural killer T cells (Q50569016) (← links)
• Immunopathogenesis of Hepatitis C Virus Infection (Q50934385) (← links)
• Hepatitis B and hepatitis C viruses: a review of viral genomes, viral induced host immune responses, genotypic distributions and worldwide epidemiology (Q56786720) (← links)
• Is vaccine therapy the future in cancer prevention? (Q56959463) (← links)
• Alterations in natural killer cells and natural killer T cells during acute viral hepatitis E (Q57071611) (← links)
• Hepatitis C Virus Infection: Host⁻Virus Interaction and Mechanisms of Viral Persistence. (Q64944307) (← links)
• Natural killer cell and hepatic cell interaction via NKG2A leads to dendritic cell-mediated induction of CD4 CD25 T cells with PD-1-dependent regulatory activities (Q79276416) (← links)
• The Interplay between Host Innate Immunity and Hepatitis E Virus (Q92852824) (← links)
• Humanized Mouse Models for the Study of Hepatitis C and Host Interactions (Q92856183) (← links)
• GPBAR1 Functions as Gatekeeper for Liver NKT Cells and provides Counterregulatory Signals in Mouse Models of Immune-Mediated Hepatitis (Q92938715) (← links)
• Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment (Q94453487) (← links)